Scientific Advisory Board

Dr. Regis DeSilva, MD

Dr. DeSilva practiced cardiology at Brigham & Women’s Hospital and at Beth Israel Deaconess Medical Center for 35 years where he was also Director of Medical Education. He is Associate Professor of Medicine at Harvard Medical School and is the author of the book ‘Heart Disease’. He was most recently Director of Global Programs at Harvard Medical International where he established programs in clinical service lines, in administrative management and in medical and nursing education. He also has a Master’s in Public Administration from the Harvard University Kennedy School of Government.

Dr. Gordon Weir, MD,

holds the Diabetes Research and Wellness Foundation Chair at Joslin, and is Professor of Medicine at Harvard Medical School. Dr. Weir served as the Medical Director of Joslin Center for Diabetes Center for nine years and, throughout, has been conducting a broad research program. Until recently, Dr. Weir was Director of the NIH supported Diabetes Research Center (DRC) of Joslin, and was Head of the Diabetes Program of the Harvard Stem Cell Institute. He is currently the Director of Joslin’s Center for Cell Transplantation. He was Editor-in-Chief of the journal Diabetes and currently acts as chairman of the JDRF Encapsulation on Consortium.

Dr. Stuart Levitz, MD

is an infectious disease specialist and a Professor at UMass Memorial Medical Center.  The Levitz lab focuses on the mechanisms by which the immune system controls fungal pathogens and the strategies that fungi utilize to circumvent host defenses.

Dr. Joe Guarnaccia, MD

is a neurologist  and an Assistant Clinical Professor at Yale Medical School. He is the director of Multiple Sclerosis Treatment Center at Griffin Health in Derby, CT. He has done innovative research in the treatment of neurodegenerative diseases and holds patents in a pioneering approach for treating MS.